|
|
This article may be too technical for most readers to understand. (April 2013) |
Cytokines (Greek cyto-, cell; and -kinos, movement) are small signaling molecules used for cell signaling. Cytokines can be classified as proteins, peptides, or glycoproteins; the term "cytokine" encompasses a large and diverse family of regulators produced throughout the body by cells of diverse embryological origin.[1]
The term "cytokine" has been used to refer to the immunomodulating agents, such as interleukins and interferons. Biochemists disagree as to which molecules should be termed cytokines and which hormones. As we learn more about each, anatomic and structural distinctions between the two are fading. Classic protein hormones circulate in nanomolar (10-9M) concentrations that usually vary by less than one order of magnitude. In contrast, some cytokines (such as IL-6) circulate in picomolar (10-12M) concentrations that can increase up to 1,000-fold during trauma or infection. The widespread distribution of cellular sources for cytokines may be a feature that differentiates them from hormones. Virtually all nucleated cells, but especially endo/epithelial cells and resident macrophages (many near the interface with the external environment) are potent producers of IL-1, IL-6, and TNF-α.[2] In contrast, classic hormones, such as insulin, are secreted from discrete glands (e.g., the pancreas).[3] As of 2008, the current terminology refers to cytokines as immunomodulating agents. However, more research is needed in this area of defining cytokines and hormones.
Part of the difficulty with distinguishing cytokines from hormones is that some of the immunomodulating effects of cytokines are systemic rather than local. For instance, to use hormone terminology, the action of cytokines may be autocrine or paracrine in chemotaxis and endocrine as a pyrogen. Further, as molecules, cytokines are not limited to their immunomodulatory role. For instance, cytokines are also involved in several developmental processes during embryogenesis[4][nb 1][5][nb 2]
Contents |
Barry Bloom and John David independently discovered and characterized the activity of a soluble molecule released from lymphocytes that inhibited the random migration of macrophages (currently known as Macrophage migration inhibitory factor). They loaded macrophages from an unimmunized animal into a capillary tube, and then placed medium from either unstimulated lymphocytes or stimulated lymphocytes. They found that the medium from the stimulated lymphocytes prevented the random migration of macrophages out of the tube. This showed that there was a way for cell-cell communication that did not require cell-cell contact.
Each cytokine has a matching cell-surface receptor. Subsequent cascades of intracellular signalling then alter cell functions. This may include the upregulation and/or downregulation of several genes and their transcription factors, resulting in the production of other cytokines, an increase in the number of surface receptors for other molecules, or the suppression of their own effect by feedback inhibition.
The effect of a particular cytokine on a given cell depends on the cytokine, its extracellular abundance, the presence and abundance of the complementary receptor on the cell surface, and downstream signals activated by receptor binding; these last two factors can vary by cell type. Cytokines are characterized by considerable "redundancy", in that many cytokines appear to share similar functions.
It seems to be a paradox that cytokines binding to antibodies have a stronger immune effect than the cytokine alone. This may lead to lower therapeutic doses.
Said et al. showed that inflammatory cytokines cause an IL-10-dependent inhibition of [6] T-cell expansion and function by up-regulating PD-1 levels on monocytes which leads to IL-10 production by monocytes after binding of PD-1 by PD-L.[7]
Adverse reactions to cytokines are characterized by local inflammation and/or ulceration at the injection sites. Occasionally such reactions are seen with more widespread papular eruptions.[8]
Cytokines have been classed as lymphokines, interleukins, and chemokines, based on their presumed function, cell of secretion, or target of action. Because cytokines are characterised by considerable redundancy and pleiotropism, such distinctions, allowing for exceptions, are obsolete.
Structural homology has been able to partially distinguish between cytokines that do not demonstrate a considerable degree of redundancy so that they can be classified into four types:
A classification that proves more useful in clinical and experimental practice divides immunological cytokines into those that enhance cellular immune responses, type 1 (IFN-γ, TGF-β, etc.), and type 2 (IL-4, IL-10, IL-13, etc.), which favor antibody responses.
A key focus of interest has been that cytokines in one of these two sub-sets tend to inhibit the effects of those in the other. Dysregulation of this tendency is under intensive study for its possible role in the pathogenesis of autoimmune disorders.
Several inflammatory cytokines are induced by oxidant stress.[9][10] The fact that cytokines themselves trigger the release of other cytokines[11][12] and also lead to increased oxidant stress makes them important in chronic inflammation, as well as other immunoresponses, such as fever and acute phase proteins of the liver (IL-1,6,12, INF-a).
In recent years, the cytokine receptors have come to demand the attention of more investigators than cytokines themselves, partly because of their remarkable characteristics, and partly because a deficiency of cytokine receptors has now been directly linked to certain debilitating immunodeficiency states. In this regard, and also because the redundancy and pleiomorphism of cytokines are, in fact, a consequence of their homologous receptors, many authorities think that a classification of cytokine receptors would be more clinically and experimentally useful.
A classification of cytokine receptors based on their three-dimensional structure has, therefore, been attempted. Such a classification, though seemingly cumbersome, provides several unique perspectives for attractive pharmacotherapeutic targets.
Adverse effects of cytokines have been linked to many disease states and conditions ranging from major depression[14] and Alzheimer's disease[15] to cancer[16] with levels either being elevated or changed. Over-secretion of cytokines can trigger a dangerous syndrome known as a cytokine storm; this may have been the cause of severe adverse events during a clinical trial of TGN1412. Cytokine storms also were the main cause of death in the 1918 "Spanish Flu" pandemic. Deaths were weighted more heavily towards people with healthy immune systems, due to its ability to produce stronger immune responses, like increasing cytokine levels. Another important[17] example of cytokine storm is seen in acute pancreatitis. Cytokines are integral and implicated in all angles of the cascade resulting in the systemic inflammatory response syndrome and multi organ failure associated with this intra-abdominal catastrophe.
Plasma levels of various cytokines may give information on the presence, or even predictive value of inflammatory processes involved in autoimmune diseases such as rheumatoid arthritis,[18] as well as immunomodulatory effects of foods or drugs.[19] In addition, elevated levels of IL-7, an important cytokine involved in T cell homeostasis, have been detected in the plasma of HIV-infected patients.[20]
| This section requires expansion. (February 2007) |
Members of the transforming growth factor beta superfamily belong to this group, including TGF-β1, TGF-β2 and TGF-β3.
| Wikimedia Commons has media related to: Cytokines |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||
|
||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
From TheJCB
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From ✁☄...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From D.Eickhoff
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From TheJCB
From TheJCB
From Myelin...
From when i...
From veny.gyurova
From Jason A....
From when i...
From æ
From marsmet511
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Vietnam...
From Alain...
Here you can share your comments or contribute with more information, content, resources or links about this topic.